Fulton Bank’s Gilead Sciences GILD Stock Holding History

Fulton Bank’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.49M	Sell	11,794 -931	-7%	-$123K	0.05%	263
2026 Q1	$1.77M	Sell	12,725 -9,171	-42%	-$1.28M	0.06%	209
2025 Q4	$2.69M	Buy	21,896 +5,968	+37%	+$725K	0.09%	156
2025 Q3	$1.77M	Sell	15,928 -5,098	-24%	-$579K	0.06%	206
2025 Q2	$2.33M	Sell	21,026 -9,389	-31%	-$999K	0.09%	166
2025 Q1	$3.41M	Sell	30,415 -3,622	-11%	-$374K	0.14%	109
2024 Q4	$3.14M	Sell	34,037 -3,518	-9%	-$317K	0.12%	124
2024 Q3	$3.15M	Buy	37,555 +5,055	+16%	+$386K	0.12%	125
2024 Q2	$2.23M	Buy	32,500 +1,007	+3%	+$67.2K	0.09%	162
2024 Q1	$2.31M	Buy	31,493 +12,775	+68%	+$982K	0.09%	162
2023 Q4	$1.52M	Sell	18,718 -171	-0.9%	-$13.3K	0.07%	211
2023 Q3	$1.42M	Buy	18,889 +678	+4%	+$52.1K	0.07%	206
2023 Q2	$1.4M	Sell	18,211 -10,710	-37%	-$854K	0.07%	205
2023 Q1	$2.4M	Sell	28,921 -29,866	-51%	-$2.47M	0.13%	139
2022 Q4	$5.05M	Sell	58,787 -598	-1%	-$47.4K	0.28%	64
2022 Q3	$3.66M	Buy	59,385 +711	+1%	+$44.8K	0.22%	82
2022 Q2	$3.63M	Buy	58,674 +6,631	+13%	+$411K	0.2%	86
2022 Q1	$3.09M	Buy	52,043 +7,319	+16%	+$468K	0.14%	113
2021 Q4	$3.25M	Sell	44,724 -686	-2%	-$47.2K	0.14%	111
2021 Q3	$3.17M	Sell	45,410 -641	-1%	-$45K	0.15%	105
2021 Q2	$3.17M	Sell	46,051 -2,334	-5%	-$156K	0.15%	107
2021 Q1	$3.13M	Sell	48,385 -6,380	-12%	-$411K	0.16%	104
2020 Q4	$3.19M	Buy	54,765 +11,303	+26%	+$682K	0.17%	98
2020 Q3	$2.75M	Buy	43,462 +20,825	+92%	+$1.44M	0.17%	101
2020 Q2	$1.74M	Sell	22,637 -46,805	-67%	-$3.59M	0.11%	137
2020 Q1	$5.19M	Buy	69,442 +2,533	+4%	+$175K	0.41%	53
2019 Q4	$4.35M	Buy	66,909 +85	+0.1%	+$5.54K	0.27%	73
2019 Q3	$4.24M	Buy	66,824 +31,050	+87%	+$2.03M	0.29%	73
2019 Q2	$2.42M	Sell	35,774 -2,591	-7%	-$170K	0.16%	112
2019 Q1	$2.49M	Sell	38,365 -3,836	-9%	-$255K	0.17%	110
2018 Q4	$2.64M	Sell	42,201 -8,193	-16%	-$573K	0.21%	96
2018 Q3	$3.89M	Sell	50,394 -6,828	-12%	-$516K	0.26%	78
2018 Q2	$4.05M	Buy	57,222 +42	+0.1%	+$2.97K	0.28%	68
2018 Q1	$4.31M	Buy	57,180 +7,961	+16%	+$633K	0.3%	62
2017 Q4	$3.53M	Sell	49,219 -938	-2%	-$71.2K	0.25%	78
2017 Q3	$4.06M	Buy	50,157 +2,391	+5%	+$183K	0.3%	65
2017 Q2	$3.38M	Buy	47,766 +4,337	+10%	+$289K	0.26%	75
2017 Q1	$2.95M	Buy	43,429 +3,253	+8%	+$229K	0.24%	83
2016 Q4	$2.88M	Sell	40,176 -525	-1%	-$39K	0.25%	81
2016 Q3	$3.22M	Sell	40,701 -3,162	-7%	-$257K	0.3%	73
2016 Q2	$3.66M	Buy	43,863 +2,947	+7%	+$262K	0.36%	65
2016 Q1	$3.76M	Sell	40,916 -2,444	-6%	-$220K	0.38%	56
2015 Q4	$4.39M	Buy	43,360 +5,133	+13%	+$534K	0.46%	48
2015 Q3	$3.75M	Buy	38,227 +1,444	+4%	+$160K	0.42%	52
2015 Q2	$4.31M	Sell	36,783 -244	-0.7%	-$26.7K	0.45%	43
2015 Q1	$3.63M	Buy	37,027 +1,097	+3%	+$111K	0.38%	48
2014 Q4	$3.39M	Sell	35,930 -600	-2%	-$62.1K	0.38%	54
2014 Q3	$3.89M	Sell	36,530 -3,248	-8%	-$318K	0.44%	42
2014 Q2	$3.3M	Sell	39,778 -7,711	-16%	-$600K	0.37%	58
2014 Q1	$3.37M	Sell	47,489 -928	-2%	-$72.8K	0.39%	53
2013 Q4	$3.64M	Sell	48,417 -15,675	-24%	-$1.09M	0.43%	50
2013 Q3	$4.03M	Sell	64,092 -2,967	-4%	-$177K	0.47%	47
2013 Q2	$3.44M	Buy	+67,059	New	+$3.5M	0.43%	58

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Fulton Bank's GILD Position: Q2 2026 in Review

Fulton Bank reduced its Gilead Sciences (GILD) stake by 7.3% in Q2 2026, selling an estimated $123K and leaving 11,794 shares worth $1.49M. The position accounts for 0.05% of the portfolio, ranked #263.

Fulton Bank first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.19M in Q1 2020. 437 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Fulton Bank held 11,794 shares of Gilead Sciences worth $1.49M as of Q2 2026.
Fulton Bank sold 931 Gilead Sciences shares in Q2 2026, an estimated $123K.
Gilead Sciences made up 0.05% of Fulton Bank's portfolio in Q2 2026, its #263 holding.
Fulton Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
Fulton Bank's Gilead Sciences position peaked at $5.19M in Q1 2020.
437 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.